ISSN: ISSN
1758-2008 (Print )
1758-2016 (Electronic)
Journal of Developing Drugs Research
Welcome to the Journal of Developing Drugs Research
Journal h-index : 32
Journal cite score : 0.55
Journal impact factor : 2.39
Average acceptance to publication time (5-7 days)
Average article processing time (30-45 days)
Editorial Board
Mark J. Ratain, MD
Editor-in-Chief
Professor, Department of Medicine, University of Chicago, USA, Expertise: Clinical pharmacology, oncology drug development
Annette C. Dolphin, PhD
Editor-in-Chief
Professor, Department of Neuroscience, Physiology, and Pharmacology, University College London, UK, Expertise: Ion channels, pharmacology of pain management
Thomas P. Davis, PhD
Editor-in-Chief
Professor, Department of Pharmaceutical Sciences, University of Colorado, USA, Expertise: Blood-brain barrier pharmacology, neuroinflammation
Journal of Developing Drugs Research (JDDR) is a peer-reviewed, open-access journal committed to publishing high-quality research in drug discovery, development, and regulatory sciences. JDDR serves as a global platform for researchers, pharmaceutical scientists, and healthcare professionals to share innovative findings, novel methodologies, and critical reviews in the field of drug research. The journal welcomes original research articles, review papers, short communications and case studies, fostering interdisciplinary collaboration and the advancement of pharmaceutical sciences.
Journal Highlights
JDDR provides a comprehensive platform covering diverse aspects of drug development, ensuring scientific progress through rigorous research and analysis. The journal upholds the highest standards by implementing a robust double-blind peer-review process, ensuring the credibility and integrity of published research. As an open-access journal, we provide unrestricted access to articles, increasing their global reach and impact. Our fast-track publication process ensures a streamlined editorial workflow, enabling the rapid dissemination of critical scientific discoveries. With a strong international presence, we engage a broad network of researchers, academicians and pharmaceutical professionals to foster collaboration and knowledge exchange.
Scope of the Journal
JDDR publishes research across various domains of drug development, including but not limited to:
- Drug Discovery and Target Identification
- Pharmacokinetics and Pharmacodynamics
- Preclinical and Clinical Drug Development
- Regulatory Affairs and Drug Approval Processes
- Pharmaceutical Formulation and Drug Delivery
- Biopharmaceuticals and Biosimilars
- Toxicology and Drug Safety Assessment
- Artificial Intelligence and Computational Drug Design
- Nanotechnology and Precision Medicine in Drug Development
- Pharmacogenomics and Personalized Medicine
Journal of Developing Drugs Research (JDDR) is dedicated to advancing pharmaceutical research and promoting high-quality scientific discourse, ensuring that the latest developments in drug discovery and development reach a broad and engaged audience.
h-index
Articles published in Journal of Developing Drugs Research (JDDR) have been cited by esteemed scholars and scientists all around the world. JDDR has got h-index 32 , which means every article in JDDR has got 32 average citations.
